BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 30547809)

  • 21. Targeting PI3Kα increases the efficacy of anti-PD-1 antibody in cervical cancer.
    Jiang W; Ouyang X; Li C; Long Y; Chen W; Ji Z; Shen X; Xiang L; Yang H
    Immunology; 2023 Nov; 170(3):419-438. PubMed ID: 37469254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
    Li L; Yang WT; Zheng PS; Liu XF
    Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.
    Jiang Y; Ren W; Wang W; Xia J; Gou L; Liu M; Wan Q; Zhou L; Weng Y; He T; Zhang Y
    Oncol Rep; 2017 Nov; 38(5):2597-2606. PubMed ID: 29048651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional role of SGK3 in PI3K/Pten driven liver tumor development.
    Cao H; Xu Z; Wang J; Cigliano A; Pilo MG; Ribback S; Zhang S; Qiao Y; Che L; Pascale RM; Calvisi DF; Chen X
    BMC Cancer; 2019 Apr; 19(1):343. PubMed ID: 30975125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.
    Zhao K; Zhou Y; Qiao C; Ni T; Li Z; Wang X; Guo Q; Lu N; Wei L
    J Hematol Oncol; 2015 Apr; 8():41. PubMed ID: 25902914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/β-catenin-Lin28/let7-PDK1 cascade.
    Cai CF; Ye GD; Shen DY; Zhang W; Chen ML; Chen XX; Han DX; Mi YJ; Luo QC; Cai WY; Yang SY
    J Exp Clin Cancer Res; 2018 May; 37(1):104. PubMed ID: 29764469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High incidence of PI3K pathway gene mutations in South Indian cervical cancers.
    Rose MM; Dhamodharan S; Revathidevi S; Chakkarappan SR; Jagadeesan MG; Subbiah S; Nakaoka H; Inoue I; Murugan AK; Munirajan AK
    Cancer Genet; 2022 Jun; 264-265():100-108. PubMed ID: 35568000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through β-catenin/c-Myc signaling pathway.
    Dai M; Song J; Wang L; Zhou K; Shu L
    J Bioenerg Biomembr; 2021 Oct; 53(5):597-608. PubMed ID: 34309767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.
    Kim HJ; Lee SY; Kim CY; Kim YH; Ju W; Kim SC
    Oncotarget; 2017 Jan; 8(4):6608-6622. PubMed ID: 28036259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin combined with nelfinavir induces SIRT3/mROS-dependent autophagy in human cervical cancer cells and xenograft in nude mice.
    Xia C; He Z; Liang S; Chen R; Xu W; Yang J; Xiao G; Jiang S
    Eur J Pharmacol; 2019 Apr; 848():62-69. PubMed ID: 30695683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
    Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
    Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIRT3 promotes the invasion and metastasis of cervical cancer cells by regulating fatty acid synthase.
    Xu LX; Hao LJ; Ma JQ; Liu JK; Hasim A
    Mol Cell Biochem; 2020 Jan; 464(1-2):11-20. PubMed ID: 31677030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycoprotein nonmetastatic melanoma protein B accelerates tumorigenesis of cervical cancer in vitro by regulating the Wnt/β-catenin pathway.
    Xu S; Fan Y; Li D; Liu Y; Chen X
    Braz J Med Biol Res; 2018 Nov; 52(1):e7567. PubMed ID: 30484490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer.
    Martell K; McIntyre JB; Kornaga EN; Chan AMY; Phan T; Köbel M; Enwere EK; Dean ML; Ghatage P; Lees-Miller SP; Doll CM
    Gynecol Oncol; 2020 Sep; 158(3):776-784. PubMed ID: 32653099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells.
    Cui Y; Qin L; Wu J; Qu X; Hou C; Sun W; Li S; Vaughan AT; Li JJ; Liu J
    PLoS One; 2015; 10(6):e0129834. PubMed ID: 26121691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA-mutant cervical carcinoma via the PI3K/AKT pathway.
    Wei Y; Lin S; Zhi W; Chu T; Liu B; Peng T; Xu M; Ding W; Cao C; Wu P
    J Med Virol; 2023 Mar; 95(3):e28656. PubMed ID: 36905114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
    Liu S; Tang Y; Yan M; Jiang W
    Invest New Drugs; 2018 Oct; 36(5):763-772. PubMed ID: 29504069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression.
    Wang Q; Qin Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Zhou D; He J
    Cell Death Dis; 2018 Jun; 9(6):668. PubMed ID: 29867145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
    Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
    [No Abstract]   [Full Text] [Related]  

  • 40. Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells.
    Yang Y; Cao Y; Chen L; Liu F; Qi Z; Cheng X; Wang Z
    Cancer Med; 2018 Sep; 7(9):4610-4618. PubMed ID: 30094960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.